Tony Hunt
Chief Executive Officer presso REPLIGEN CORPORATION
Patrimonio netto: 36 M $ in data 29/02/2024
Profilo
Attualmente, Tony J. Hunt è presidente, amministratore delegato e direttore di Repligen Corp. Hunt ha precedentemente ricoperto la posizione di Senior Director-Pharma Programs presso Applied Biosystems, Inc. e di Presidente-Bioproduction presso Life Technologies Corp. Tony J. Hunt ha conseguito una laurea e un diploma presso l'Università Nazionale d'Irlanda e un MBA presso la Questrom School of Business.
Partecipazioni note in società pubbliche
Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
---|---|---|---|---|
REPLIGEN CORPORATION
0.33% | 18/03/2024 | 183 249 ( 0.33% ) | 36 M $ | 29/02/2024 |
908 DEVICES INC.
0.03% | 04/03/2024 | 8 886 ( 0.03% ) | 65 312 $ | 29/02/2024 |
Posizioni attive di Tony Hunt
Società | Posizione | Inizio |
---|---|---|
REPLIGEN CORPORATION | Chief Executive Officer | 21/05/2015 |
908 DEVICES INC. | Director/Board Member | 02/03/2022 |
Precedenti posizioni note di Tony Hunt
Società | Posizione | Fine |
---|---|---|
Life Technologies Corp.
Life Technologies Corp. Miscellaneous Commercial ServicesCommercial Services Life Technologies Corp. provides products in the areas of scientific research, genetic analysis and applied sciences. Its brands include Invitrogen, Applied Biosystems, Gibco, Molecular Probes, Noves, Ambion and Ion Torrent. The firm’s portfolio includes the most cited products and technologies in qPCR, capillary electrophoresis sequencing, nextgeneration sequencing, molecular diagnostics, forensics, cell culture and analysis, and agriculture research. The company was founded on November 21, 2008 and is headquartered in Carlsbad, CA. | Corporate Officer/Principal | 01/01/2014 |
Applied Biosystems, Inc.
Applied Biosystems, Inc. Medical SpecialtiesHealth Technology Applied Biosystems, Inc. is a company that provides integrated systems for sequencing, flow cytometry, and various types of PCR. The company is based in Foster City, CA. The company's products cover the entire process from sample preparation to data analysis. The company was founded by Chris Yoo, Marvin H. Caruthers, Michael W. Hunkapiller, and Leroy E. Hood. Applied Biosystems was acquired by Invitrogen Corp. from Applera Corp. on November 21, 2008 for $6,417.85 million. | Corporate Officer/Principal | 01/01/2008 |
Formazione di Tony Hunt
National University of Ireland | Graduate Degree |
Questrom School of Business | Masters Business Admin |
Esperienze
Posizioni ricoperte
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 2 |
---|---|
REPLIGEN CORPORATION | Health Technology |
908 DEVICES INC. | Health Technology |
Aziende private | 2 |
---|---|
Applied Biosystems, Inc.
Applied Biosystems, Inc. Medical SpecialtiesHealth Technology Applied Biosystems, Inc. is a company that provides integrated systems for sequencing, flow cytometry, and various types of PCR. The company is based in Foster City, CA. The company's products cover the entire process from sample preparation to data analysis. The company was founded by Chris Yoo, Marvin H. Caruthers, Michael W. Hunkapiller, and Leroy E. Hood. Applied Biosystems was acquired by Invitrogen Corp. from Applera Corp. on November 21, 2008 for $6,417.85 million. | Health Technology |
Life Technologies Corp.
Life Technologies Corp. Miscellaneous Commercial ServicesCommercial Services Life Technologies Corp. provides products in the areas of scientific research, genetic analysis and applied sciences. Its brands include Invitrogen, Applied Biosystems, Gibco, Molecular Probes, Noves, Ambion and Ion Torrent. The firm’s portfolio includes the most cited products and technologies in qPCR, capillary electrophoresis sequencing, nextgeneration sequencing, molecular diagnostics, forensics, cell culture and analysis, and agriculture research. The company was founded on November 21, 2008 and is headquartered in Carlsbad, CA. | Commercial Services |